A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma (HNSCC)

被引：0
|
作者：
Yang, E. S. [1 ]
Deutsch, E. [2 ]
Mehmet, A. [3 ]
Fayette, J. [4 ]
Nabell, L. [5 ]
Spencer, S. A. [1 ]
Dobelbower, M. C. [1 ]
Willey, C. D. [1 ]
Bonner, J. A. [1 ]
Wang, X. [6 ]
Lin, A. [6 ]
William, W. N. [7 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Paris Saclay, Gustave Roussy, Villejuif, France
[3] MD Anderson, Houston, TX USA
[4] Univ Lyon, Ctr Leon Berard, Ctr Canc, Clin Oncol, Lyon, France
[5] Univ Alabama Birmingham, Ctr Comprehens Canc, Clin Studies Unit, Birmingham, AL 35294 USA
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 106卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
201
引用
收藏
页码：1136 / 1136
页数：1
相关论文
共 50 条
  • [1] A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma
    Yang, Eddy S.
    Deutsch, Eric
    Mehmet, Altan
    Fayette, Jerome
    Tao, Yungan
    Nabell, Lisle
    Spencer, Sharon A.
    Wang, Xuejing A.
    Spoljoric, Elizabeth A.
    Zhang, Wei
    Hynes, Scott M.
    Decker, Rodney L.
    Lin, Aimee K. Bence
    William, William N., Jr.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 157 : 203 - 209
  • [2] Phase 1b trial of LY2606368 in combination with chemoradiation in patients with locally advanced head and neck squamous cell cancer
    Yang, E.
    William, W.
    Fayette, J.
    Zhang, W.
    Fink, A.
    Lin, A. B.
    Deutsch, E.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [3] Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Harrington, Kevin J.
    El-Hariry, Iman A.
    Holford, Clare S.
    Lusinchi, Antoine
    Nutting, Christopher M.
    Rosine, Dominique
    Tanay, Mary
    Deutsch, Eric
    Matthews, Jennifer
    D'Ambrosio, Consuelo
    Turner, Simon J.
    Pandeshwara, Jagannatha S.
    Bourhis, Jean
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1100 - 1107
  • [4] CTEP 10492, a phase 1/1b study of the AKT inhibitor ipatasertib with chemoradiation for locally advanced head and neck squamous cell carcinoma
    Mattes, Malcolm David
    Willers, Henning
    Lin, Yong
    Gharzai, Laila A.
    Alesi, Erin R.
    Lominska, Christopher E.
    Kim, Sung
    Haigentz, Missak
    Kaur, Varinder
    Arnold, Susanne M.
    Synold, Timothy W.
    Gutkind, J. Silvio
    Wirth, Lori J.
    Hanker, Ariella
    Said, Rabih
    Siu, Lillian L.
    Jabbour, Salma K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer
    Chen, Changhu
    Kane, Madeleine
    Song, John
    Campana, John
    Raben, Adam
    Hu, Kenneth
    Harrison, Louis
    Quon, Harry
    Dancey, Janet
    Baron, Anna
    Said, Sherif
    Eckhardt, S. Gail
    Raben, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 4880 - 4886
  • [6] A Phase 1 Trial of Ketogenic Diet With Concurrent Chemoradiation (CRT) in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Anderson, C. M.
    Loth, E.
    Opat, E.
    Bodeker, K.
    Ahmann, L.
    Parkhurst, J.
    Sun, W.
    Furqan, M.
    Laux, D.
    Brown, H.
    Vollstedt, S.
    Follmer, K.
    Ma, D.
    Spitz, D.
    Fath, M.
    Buatti, J.
    Allen, B. G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 898 - 898
  • [7] PEP503 (NBTXR3), a radioenhancer, in combination with concurrent chemoradiation (CCRT) in locally advanced or recurrent head and neck squamous cell carcinoma (HNSCC): Dose-finding of a phase 1b/2 trial.
    Wang, Cheng-Hsu
    Chao, K. S. Clifford
    Chen, Ping-Tsung
    Yeh, Kun-Yun
    Chen, Yen-Chao
    Chen, Yao-Liang
    Yang, Shih-Wei
    Wu, Tsung-Han
    Chang, Pei-Hung
    Young, Chi-Kuang
    Tsan, Din-Li
    Tsai, Ming-Hsui
    Hsieh, Ching-Yun
    Chen, Wen-Cheng
    Tsai, Yuan-Hsiung
    Hsu, Cheng-Ming
    Chang, John W. C.
    Yu, Wei-Che
    Shen, Bor-Nian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18041 - E18041
  • [8] Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trial
    Arias de la Vega, F.
    Contreras, J.
    de las Heras, M.
    de la Torre, A.
    Arrazubi, V.
    Herruzo, I.
    Prieto, I.
    Garcia-Saenz, J. A.
    Romero, J.
    Calvo, F. A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (04) : 1005 - 1009
  • [9] Prognostic significance of plasma osteopontin in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with chemoradiation on TROG 02.02 phase III trial.
    Lim, A. M. L.
    Rischin, D.
    Cao, H.
    Fisher, R.
    McArthur, G. A.
    Peters, L. J.
    Young, R. J.
    Le, Q.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Phase II trial of valproic acid combined with cisplatin-based chemoradiation in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) patients (pts).
    Mak, Milena Perez
    Pasini, Fatima Solange
    Diao, Lixia
    Garcia, Fabyane Oliveira Teixeira
    Takahashi, Tiago Kenji
    Amadio, Alex Vitorio
    Siqueira, Sheila Aparecida Coelho
    Sichero, Laura
    Snitcovsky, Igor M. L.
    Kulcsar, Marco Aurelio Vamondes
    Wang, Jing
    Castro, Gilberto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345